| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/13/1987 | US4636469 Isolation of hepatitis A virus strain HM-175 |
| 01/13/1987 | US4636463 Antibodies to human interleukin-2 induced by synthetic polypeptides |
| 01/13/1987 | US4636385 Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection |
| 01/13/1987 | US4636384 Method for treating disorders of the vascular and pulmonary systems |
| 01/10/1987 | CN85101017A Lyophilized hepatitis b vaccine |
| 01/10/1987 | CN85100949A Synthetic genes for bovine parainfluenza virus |
| 01/07/1987 | EP0207557A2 Diphosphonate-derivatized macromolecules |
| 01/06/1987 | US4634666 Triomas secreting monoclonal antibodies |
| 01/06/1987 | US4634664 Hybridomas |
| 01/06/1987 | US4634590 Cell membrane proteins, compositions containing them and procedure for their preparation |
| 01/06/1987 | CA1216235A1 Multivalent pneumococcal vaccine and preparation thereof |
| 01/06/1987 | CA1216234A1 Preparation of modified strains of bovine diarrhoea virus and vaccines containing them |
| 01/06/1987 | CA1216231A1 Bispecific antibody determinants |
| 12/31/1986 | CN85103413A Process for the preparation of live virus purified vaccine |
| 12/30/1986 | US4632980 Ozone decontamination of blood and blood products |
| 12/30/1986 | US4632830 Typhoid, dysentery, genetic engineering |
| 12/30/1986 | EP0206942A1 DNA sequences of Archae bacteria, homologous to the v-myc oncogene, proteins encoded by these sequences, processes to obtain them and their immunological applications |
| 12/30/1986 | EP0206852A1 Conjugate constituted by a proteic surface adhesive of Streptococcus mutans, and by a polysaccharide of Streptococcus mutans, its preparation and its use, particularly in anti-caries vaccines |
| 12/30/1986 | EP0206849A2 Method for the diagnosis in vitro of malignant cells originating from the digestive duct |
| 12/30/1986 | EP0206842A1 Antigens related to the envelope glycoprotein of the acquired immunodeficiency syndrome virus |
| 12/30/1986 | EP0206533A2 Platelet inhibiting monoclonal antibody fragment |
| 12/30/1986 | EP0206532A2 Fibrinogen blocking monoclonal antibody |
| 12/30/1986 | EP0206400A1 New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies |
| 12/30/1986 | EP0206077A2 Device for the separation of magnetic particles in the fluid phase |
| 12/30/1986 | EP0206037A2 Carbamates and ureas of N-(2-aminoacylamido-2-desoxy-hexosyl) amide, method for their preparation and their pharmaceutical use |
| 12/30/1986 | EP0205625A1 Hepatitis b virus vaccine and process for its preparation |
| 12/30/1986 | EP0205547A1 A compound and a composition for therapeutic or diagnostic use and the use of such compound and composition for therapeutic treatment and isolation of shigatoxine |
| 12/30/1986 | CA1215919A1 Detection of malignant tumor cells |
| 12/30/1986 | CA1215891A1 Disease control in avian species by embryonal vaccination |
| 12/24/1986 | CN85104796A Method for the production of vaccine |
| 12/18/1986 | WO1986007383A1 Autoantigen vaccines |
| 12/18/1986 | WO1986007382A1 Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a |
| 12/18/1986 | WO1986007365A1 Products resulting from the conjugation of a macromolecular support, a hapten and a muramyl-peptide |
| 12/17/1986 | EP0205405A2 Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications |
| 12/17/1986 | EP0205404A2 Hybrid interferons |
| 12/17/1986 | EP0205352A2 Monoclonal anti-human IgG4 antibodies, their production and use |
| 12/17/1986 | EP0205337A2 Chondrocyte antigens and monoclonal antibodies |
| 12/17/1986 | EP0205326A2 Antibody conjugates |
| 12/17/1986 | EP0205177A2 Method of assaying myosin light chain |
| 12/17/1986 | EP0205098A2 Influenza vaccine |
| 12/17/1986 | EP0205046A2 Monoclonal antibody to human protein C |
| 12/17/1986 | EP0204922A2 Immunohistochemical assay for detection of a tumor-associated marker (p53) |
| 12/17/1986 | EP0201413A1 Compounds causing the production of antibodies, immunogenic and immunoprotective compositions containing them, and process for obtaining antibodies by using them |
| 12/17/1986 | CN86100979A Process for the preparation malaria vaccine |
| 12/16/1986 | US4629783 Polypeptides |
| 12/16/1986 | US4629722 Method of inhibiting the onset of acute radiation syndrome |
| 12/16/1986 | US4629689 Binding assay with amplified read-out and gas-phase detection |
| 12/10/1986 | EP0204680A2 Process for isolating and purifying the hepatitis B surface antigen |
| 12/10/1986 | EP0204566A2 Birth control vaccine |
| 12/10/1986 | EP0204480A2 Synthetic vaccines for foot and mouth disease |
| 12/10/1986 | EP0203917A1 Metabolic improvement method by potentiated self-hemostimulation |
| 12/10/1986 | CN85104643A Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production |
| 12/09/1986 | US4628035 Immunoassay method |
| 12/09/1986 | US4628032 Monoclonal antibody specific for a mammary tumor cytoplasmic antigen |
| 12/04/1986 | WO1986007062A1 Monoclonal antibody to decay accelerating factor (daf), a method for making it, and use |
| 12/04/1986 | WO1986007060A1 Cloning and expression of host-protective immunogens of ibdv |
| 12/04/1986 | WO1986006963A1 Process for preparing gamma-globulins supplied by intravenous administration and gamma-globulins obtained |
| 12/03/1986 | EP0203909A1 Early-summer meningo-encephalitis virus (FSME-virus) vaccine, and method of producing the same |
| 12/03/1986 | EP0203865A1 Process for the separation of antifactor VIII:C antibodies, especially for use in the blood plasma purification of a type A haemophiliac |
| 12/03/1986 | EP0203676A2 Vaccine for generating an immunogenic T cell response protective against a virus |
| 12/03/1986 | EP0203587A2 Ras oncogene peptides and antibodies |
| 12/03/1986 | EP0203586A2 A composition for treating gastrointestinal disease in animals |
| 12/03/1986 | EP0203552A2 Monoclonal antibodies for human non-small cell lung carcinomas |
| 12/03/1986 | EP0203177A1 Polypeptides and antibodies related to deglycosylated viral glycoproteins |
| 12/02/1986 | US4626502 Using achromopeptidase to detect streptococcus |
| 12/02/1986 | US4626430 Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom |
| 12/02/1986 | CA1214724A1 Vaccine for bluetongue disease employing platinum compounds |
| 11/26/1986 | EP0202947A2 Vaccine production |
| 11/26/1986 | EP0202642A2 Process for the in vitro immunization of human splenocytes against tumor associated antigens |
| 11/25/1986 | US4625015 Broad spectrum influenza antisera |
| 11/25/1986 | US4625014 Cell-delivery agent |
| 11/25/1986 | US4624921 Cultures, fusion |
| 11/25/1986 | US4624918 Purification process for hepatitis surface antigen and product thereof |
| 11/25/1986 | US4624850 Live attenuated human rotavirus vaccine |
| 11/20/1986 | WO1986006727A1 PREPARATION OF MONOMERIC IgG |
| 11/20/1986 | WO1986006635A1 Oral vaccines |
| 11/20/1986 | WO1986006634A1 Mastitis vaccine |
| 11/20/1986 | EP0202142A1 Avirulent rabies vaccine |
| 11/20/1986 | EP0201796A2 Treponema hyodysenteriae bacterin and process for preparing it |
| 11/20/1986 | EP0201716A2 Expression of immunologically reactive viral proteins |
| 11/20/1986 | EP0201568A1 Anthelmintic vaccines comprising a nematode species |
| 11/20/1986 | EP0201520A1 Monoclonal antibodies and their use |
| 11/20/1986 | EP0201519A1 Monoclonal antibodies and their use |
| 11/19/1986 | CN86102113A Process for preparing hepatitis b surface antigen containing particies in novel forms which are highly immunogenic |
| 11/19/1986 | CN85108890A Methods of preparing covalently-modified neutral bacterial poly-saccharides and thereof covalent conjugates of such polysaccharides and immunogenic proteins |
| 11/18/1986 | US4623717 Pasteurized therapeutically active protein compositions |
| 11/18/1986 | CA1214124A1 Monoclonal antibody covalently linked to the toxin ricin |
| 11/18/1986 | CA1214122A1 Poliovirus-neutralizing-monoclonal antibodies and hybridomas secreting said antibodies |
| 11/18/1986 | CA1214103A1 Lectin-containing anti-viral vaccines for domestic animals and method of preparation |
| 11/12/1986 | EP0201420A1 2-(2-Acetamido-2-deoxy-3-O-D-glucopyranosyl)-alkanoyl-aminoacyl-nor leucin glycopeptides or derivatives of these glycopeptides, and immunoadjuvant compositions containing them |
| 11/12/1986 | EP0201416A1 Particles having immunogen HBs antigen properties and bearing an antigenic site, foreign to the epitopes of HBs antigen, vectors and animal cells for the production of those particles of mixed vaccines |
| 11/12/1986 | EP0201187A1 Determination of glycated (glycosylated) hemoglobin in blood |
| 11/12/1986 | EP0201086A2 Method of producing useful high-molecular-weight substances by culturing proliferous animal cells and culture system therefor |
| 11/12/1986 | EP0201053A1 Use of pollen extracts for producing pharmaceutical preparations for the prophylactic treatment of allergies |
| 11/12/1986 | EP0201004A2 Polyvalent hyperimmunoglobulin preparation |
| 11/12/1986 | EP0200960A1 Total estriol fluorescence polarization immunoassay |
| 11/12/1986 | CA1213841A Hybrid cell line for producing complement-fixing monoclonal antibody to mouse i-a antigen and to i-a analogous antigens on human and other animal lymphocytes, antibody and methods |
| 11/12/1986 | CA1213828A Purified and antigenically selective vaccines for domestic animals |
| 11/11/1986 | USRE32283 Infectious bronchitis |
| 11/11/1986 | US4622223 Broad spectrum vaccine against gonorrhea |